i-Seq Biotechnology Revenue

Hospitals and Health Care • Mobile, Alabama, United States • 1-10 Employees

i-Seq Biotechnology revenue & valuation

Annual revenue	$256,665
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Hospitals and Health Care industry and current estimated revenues	$821,328
Total funding	No funding

Key Contact at i-Seq Biotechnology

Michael Artinger

Chief Executive Officer | Chair, Board of Directors | Co-Founder

Company overview

Headquarters	Mobile, Alabama, United States
Website	i-seq.com
NAICS	92312
Founded	2024
Employees	1-10

i-Seq Biotechnology Email Formats

i-Seq Biotechnology uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@i-seq.com), used 100% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@i-seq.com	100%

About i-Seq Biotechnology

i-Seq Biotechnology, Inc. was formed in 2024 to advance novel, broad-spectrum, vaccines and therapeutics against infectious disease pathogens impacting human health globally.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

i-Seq Biotechnology has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

i-Seq Biotechnology has never raised funding before.

i-Seq Biotechnology Tech Stack

Discover the technologies and tools that power i-Seq Biotechnology's digital infrastructure, from frameworks to analytics platforms.

Flying Pages

Performance

Underscore.js

JavaScript libraries

Elementor Header & Footer Builder

WordPress plugins

iubenda

Cookie compliance

Flying Images

WordPress plugins

Animate.css

UI frameworks

Elementor

Page builders

Statically

CDN

jQuery Migrate

JavaScript libraries

Apache HTTP Server

Web servers

jQuery

JavaScript libraries

PHP

Programming languages

Frequently asked questions

i-Seq Biotechnology is located in Mobile, Alabama, US.

i-Seq Biotechnology generates an estimated annual revenue of $256,665. This revenue figure reflects the company's market position and business performance in its industry.

i-Seq Biotechnology has an estimated valuation of $821,328. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

i-Seq Biotechnology was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.

i-Seq Biotechnology has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at i-Seq Biotechnology

Michael Artinger

Chief Executive Officer | Chair, Board of Directors | Co-Founder

4.8

40,000 users